|
|
 |
 |
 |
OSTEOBIT: Portable Focused Osteogenetic Therapy |
OSTEOBIT
An innovative solution to enhance the regenerative activity of bone tissue.
With OSTEOBIT IGEA confirms once again its commitment in orthopaedics and traumatology providing the patient with the most up-to-date solutions.
OSTEOBIT, like all IGEA technologies, has a documented clinical efficacy.
Clinical studies carried out with OSTEOBIT have demonstrated an 84% success rate in the treatment of failed consolidations.
OSTEOBIT, small and light, easy to use and compatible with the normal daily activities, is the optimum for treating:
. recent fractures
. stress fractures
. failed consolidations
View Radiographies
OSTEOBIT is a highly reliable device, manufactured following the most severe European directives on safety. It is built in accord with IEC 601-1directives, its electrical safety is homologated by IMQ, it respects the requirements of the 93/42/CEE directive and is marked CE0051.
Continue... |
 |
|
|
|
|
|
| |
|
Home
|
Company
|
Diagnostics
|
Oncology
|
Orthopaedic
|
Information
|
Site map |
| |
|
|
|
|
|
|
|
| |
IGEA S.p.A. Via Parmenide, 10/A - 41012 CARPI (MO) ITALY
C.F. e P.I. 01021130362 – Capitale Sociale € 163.450,00 i.v.
- REA 205183 - Reg. Soc. Trib. 14968
- Iscritto nelle imprese di Modena |
|
